RxDoctor Payments Data

Jessica Thomas

Psychiatric/Mental Health · Iowa City, IANPI 1467802124

Payments from drug & device makers

$1,495in general payments, 2019–2025

Across 49 payments — averaging $30.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$713
  • AbbVie$215
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$118
  • Sunovion Pharmaceuticals Inc.$94
  • Neurocrine Biosciences, Inc.$75
  • Teva Pharmaceuticals USA, Inc.$72
  • plus $208 from 5 others

What the payments were for

  • Travel & lodging$71348%
  • Food & beverage$78252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,495 in reported general payments places this provider in the 65th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$14,337
Medicare patients
71
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Risperdal ConstaRisperidone Microspheres14$8,804
BelsomraSuvorexant11$4,757
Duloxetine Hcl91$1,679
Bupropion XlBupropion Hcl84$1,632
Buspirone Hcl139$1,334
Aripiprazole42$1,200
Trazodone Hcl210$1,164
Escitalopram Oxalate216$1,160
Quetiapine Fumarate61$1,038
Venlafaxine Hcl ErVenlafaxine Hcl114$856
Venlafaxine Hcl26$670
Doxepin Hcl22$634
Mirtazapine53$528
Hydroxyzine Hcl24$488
Lorazepam67$360

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonRisperdal Consta$56$8,80414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →